The Hematologist | American Society of Hematology

Skip Nav Destination

Clinical Trials Corner

Alliance A042001: A randomized Clinical Trial to Determine Whether Inotuzumab + Mini-HyperCVD Will Replace HyperCVAD As Frontline Treatment in Older Adult ALL
Feature

Clonal Hematopoiesis in Inherited Bone Marrow Failure Syndromes: Adaptive Origins With Maladaptive Consequences?
Podcast

ASH Summit on Immunotherapies for Hematologic Diseases, With Dr. Terry Fry and Dr. Shaji Kumar

Committee on Practice Chair Speaks on the Need for Advocacy in the New Congress

ASH Committee on Practice Chair Dr. Chancellor Donald discusses the need to educate lawmakers about issues affecting hematology patient care. Read More

Current Issue

Volume 20,

Issue 2,

March-April 2023

View This Issue

Latest Articles

Advancements and Challenges in Hematology: From Bone Marrow Transplants to Targeted Therapeutics

Clonal Hematopoiesis in Inherited Bone Marrow Failure Syndromes: Adaptive Origins With Maladaptive Consequences?

ALLIANCE A042001: A Randomized Clinical Trial to Determine Whether Inotuzumab + Mini-HyperCVD Will Replace HyperCVAD As Frontline Treatment in Older Adult ALL

Platelets and Parturition: The Clinical Course of ITP in Pregnancy

Langerhans Cell Histiocytosis in the Adult: A Commentary on Diagnosis, Treatment, and Surveillance

Hyperpigmentation of the Tongue in a Patient With Lymphoma

Size Matters in Lymphoma Diagnosis Tissue Biopsy

Not Just Caused by Getting Old: Germ Line Predisposition Identified in Patients of All Ages with Myelodysplastic Syndrome

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-analysis of Randomized Trials

Is It an Ember or Is It a Flame? The Natural History of Smoldering Multiple Myeloma

President's Column

Advancements and Challenges in Hematology: From Bone Marrow Transplants to Targeted Therapeutics

March 1, 2023
ASH President Dr. Robert Brodsky dives into how recent advancements open doors in hematologic care and create new obstacles like care accessibility and survivorship.

View all president's column articles

Alliance A042001: A randomized Clinical Trial to Determine Whether Inotuzumab + Mini-HyperCVD Will Replace HyperCVAD As Frontline Treatment in Older Adult ALL

Clonal Hematopoiesis in Inherited Bone Marrow Failure Syndromes: Adaptive Origins With Maladaptive Consequences?

ASH Summit on Immunotherapies for Hematologic Diseases, With Dr. Terry Fry and Dr. Shaji Kumar

Committee on Practice Chair Speaks on the Need for Advocacy in the New Congress

Latest Articles

President's Column

Advancements and Challenges in Hematology: From Bone Marrow Transplants to Targeted Therapeutics

Featured Content

Langerhans Cell Histiocytosis in the Adult: A Commentary on Diagnosis, Treatment, and Surveillance

Is It an Ember or Is It a Flame?

Daratumumab, Lenalidomide, and Dexamethasone for High-Risk Smoldering Multiple Myeloma

ASH Publications

American Society of Hematology

Latest Articles

President's Column

Featured Content

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only